The European Commission’s decision is based on two Phase III trials where Tevimbra plus chemotherapy improved overall ...

New data collected by the FDA has found that montelukast can bind to brain cells, which may explain the risk of mental health ...

Rabbit Monoclonal Primary Antibody test as a companion diagnostic to assess HER2+ status in patients with BTC.

Vaping is coming before the Supreme Court next week as federal regulators ask the high court to uphold its block on sweet, ...

The U.S. Food and Drug Administration has approved UCB's Bimzelx (bimekizumab-bkzx) for the treatment of adults with moderate ...

A new therapy for brittle type 1 diabetes, the only treatment currently approved by the U.S. Food and Drug Administration, is ...

Imatinib oral solution has gained FDA approval for the treatment of some cancers, including certain forms of leukemia.

Sacral neuromodulation is an advanced therapy for people with bladder and bowel control issues that are not responding to ...

Acoramidis becomes the second drug ever approved for this condition, based on the results of the ATTRibute-CM trial.

With approval, acoramaidis (Attruby; BridgeBio Pharma) becomes the first agent with a label specifying near-complete ...

The FDA has approved Attruby, a new oral treatment that helps reduce heart-related deaths and hospital visits among adults ...

Applied Therapeutics said on Wednesday that the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic ...